DTx Europe 2023
5th Annual

DTx Europe 2023

The Meeting Point For the Digital Therapeutics Community

June 28-29th | London, UK | BST Timezone

Registration Agenda

2023 Partners

Knowledge Partner
Knowledge Partner

IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare forward. Together with the companies we serve, we are enabling a more modern and effective healthcare system and creating breakthrough solutions that transform business and patient outcomes.

Learn more

Supporter
Supporter

At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.

Learn More

Key Features
2 DAYS OF LEARNING

DTx Europe is coming back to London ! Bringing you 2 days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. Join us on Day 1 for the first ever tracked DTx Europe, splitting into The Evidence and The Commercial paths. Whatever you’re looking for we got you covered!

CAREFULLY CRAFTED AGENDA BUILT AROUND KEY TOPICS

Experts from every stakeholder within the digital therapeutics space will be coming down to London in June 2023. Calling to every corner of the industry, join your peers from leading DTx companiesPharmaPayersProviders, Government BodiesAcademiaPolicy Makers and more. Step away from the screen for 2 days of industry-defining discussions and catch up with old and make new connections within the field.

Personalised Participation
SENIOR & MULTIFACETED COMMUNITY

The time has come to meet in-person once again! Join your peers for live presentations and engaging discussionsDTx Europe will be diving into key areas such as CommercialisationRegulation, Clinical Trials, Patient InsightsProvider AdoptionUser Engagement

Partnerships and more. No matter where your interest lies, we’ve got you covered.

“It is by far the people that make these DTx events. The DTx series brings some of the best in class, and I look forward to seeing the group four times a year.”

Jon Kizner - Senior Vice President of Business Development, EVERSANA

“The DTx Europe conferences remain the most important event for the digital therapeutics space in Europe. This is my primary go-to event, when I want to know the latest and greatest, and meet my peers to exchange ideas and insights.”

Kim Baden-Kristensen - CEO & Co-Founder, Brain+

“You’re really following the conversations that are happening and so a lot of times when I look at the agenda I think ‘these are exactly all the things that I want to talk or hear about’

Kamal Jethwani - Co-Founder & CEO, Decimal.health

“DTx Europe is one of the most exciting events of the year in healthcare – where we hear from leaders who are pushing the boundaries to deliver world-class care for patients globally. Really looking forward to the next event!”

Mala Mawkin - Leva Clinic, Head of Market Development

I just see digital health, connected devices, digital therapeutics as the next generation of how we improve patient outcomes. And it’s the reason why we come to DTx because it’s the one event where everyone here has that same mission.

Steve LoSardo - VIce President, Sympatient

“This is a must-attend event for everyone involved in digital therapeutics and digital care companions. In a phase of steady growth for the DTx market, I can’t wait to join my peers and get their perspectives at the next DTx Europe”

Quentin Le Masne - Head of Development & Innovation - Connected Health & Devices. Merck Group

2023 Speaker Faculty

Ali Hasan
Ali Hasan
Chief Medical & Healthcare officer
Vitality
Ali Hasan
Chief Medical & Healthcare officer
Vitality
Louisa Stuwe
Louisa Stuwe
Project Director - Ministerial Digital Health Delegation
French Ministry of Health
Louisa Stuwe
Project Director - Ministerial Digital Health Delegation
French Ministry of Health
Edouard Gasser
Edouard Gasser
Co-Founder & CEO
Tilak healthcare
Edouard Gasser
Co-Founder & CEO
Tilak healthcare

Edouard is the Co-Founder and CEO of Tilak Healthcare, a unique video game studio creating clinically validated medical mobile games to help monitor and rehabilitate patients affected by chronic diseases.

For more than 10 years, Edouard worked in the video game industry at Gameloft, a company developing and editing mobile video games, where he successively held the positions of Project manager in Paris, then Lead Producer in New Orleans and finally managing Director of Gameloft Madrid.

Driven by his passion for innovation and technology, he was also a writer for TechCrunch France, covering mobile apps, 2.0 web and entertainment topics.

Jennifer Goldsack
Jennifer Goldsack
Chief Executive Officer
Digital Medicine Society
Jennifer Goldsack
Chief Executive Officer
Digital Medicine Society
Michelle Olschewski
Michelle Olschewski
Chief Operating Officer
ViViRA
Michelle Olschewski
Chief Operating Officer
ViViRA
Dennis Hermann
Dennis Hermann
Head of Europe
Kaia Health
Dennis Hermann
Head of Europe
Kaia Health
Dennis Hermann leads the EU Business Development Team at Kaia Health. His team is responsible in broadening the options for the organisation by identifying and capturing new opportunities across the value chain to generate value for patients and health care professionals.
Prior to Kaia Health, Dennis was the COO of a confectionery company, and worked on real estate, private equity and M&A projects for various financial services companies. Dennis holds an MSc in Innovation and Entrepreneurship from ESADE Business School in Barcelona and a Bachelor’s Degree in Business Administration from University of St. Gallen.
Anna Haas
Anna Haas
Managing Director of Europe
Oviva
Anna Haas
Managing Director of Europe
Oviva
Kim Baden-Kristensen
Kim Baden-Kristensen
Co-Founder & CEO
Brain+
Kim Baden-Kristensen
Co-Founder & CEO
Brain+
Lily Tang
Lily Tang
Deputy Director, Digital Investment Strategy
NHS
Lily Tang
Deputy Director, Digital Investment Strategy
NHS
Matthias Zenker
Matthias Zenker
Chief Medical Solutions Officer
GAIA AG
Matthias Zenker
Chief Medical Solutions Officer
GAIA AG

Matthias is a physician by training and holds a medical doctorate degree from the University of Ulm, Germany. He has gained both inpatient and outpatient medical expertise in various healthcare systems around the world. Matthias joined GAIA over 20 years ago. In his current role as Chief Medical Solutions Officer, Matthias is responsible for leveraging GAIA’s decades of DTx medical research and expertise internationally and providing integrated solutions to payer and physician organizations.

Ariel Dora Stern
Ariel Dora Stern
Associate Professor
Harvard Business School
Ariel Dora Stern
Associate Professor
Harvard Business School
Kathrin Pfeiffer
Kathrin Pfeiffer
Head of Market Access
Sympatient
Kathrin Pfeiffer
Head of Market Access
Sympatient

After a medical apprenticeship and studies in medical technology, I worked as a scientific
employee at the Federal Institute for Drugs and Medical Devices for more than seven years.
Among others, in the areas of approval of clinical trials with medical devices and vigilance.
The last two years were spent in the field of digital health applications (DiGA) as deputy
head of the according unit. In this area, I was intensively involved in the development of the
German DiGA fast-track and helped to design it. Since January 22, I have been in charge of
market access at Sympatient and now dedicate myself to solving the worldwide anxiety
crisis.

Laurenz Von Landenberg
Laurenz Von Landenberg
Deputy Head of Unit DiGA-Fast-Track
BfArM
Laurenz Von Landenberg
Deputy Head of Unit DiGA-Fast-Track
BfArM
Francesca Wuttke
Francesca Wuttke
Founder & CEO
nen
Francesca Wuttke
Founder & CEO
nen
Yoann Sapanel
Yoann Sapanel
Head, Healthy Innovation
Institute for Digital Medicine
Yoann Sapanel
Head, Healthy Innovation
Institute for Digital Medicine
Rayna Patel
Rayna Patel
Co0Founder & CEO
Vinehealth
Rayna Patel
Co0Founder & CEO
Vinehealth

Dr Rayna Patel is a medical doctor & neuroscientist with an MPhil in Translational Medicine. She has extensive experience in academia (Cambridge, Harvard, MIT, Columbia) and was an Associate Fellow of Clare Hall College, Cambridge. Rayna has subsequently held strategic & commercial roles in government policy, tech startups & the Cabinet Office’s Nudge Unit, where she used behavioural science to rewire patient behaviours through digital products.
She is currently CEO and Co-Founder of Vinehealth, a digital platform using a combination of behavioural science and AI to improve the quality of life and survival of cancer patients, whilst generating crucial real-world data to better inform healthcare delivery and drug development.

Christian Angern
Christian Angern
Co-Founder & Managing Director
Sympatient
Christian Angern
Co-Founder & Managing Director
Sympatient

As co-founder and managing director Christian is in charge of sales, market access, and reimbursement for Sympatient – the first digital anxiety clinic. He has a strong passion for solving complex problems in healthcare systems to ultimately enable better access to care for patients. Christian holds a degree in economics from Jacobs University, an MPhil from the University of Cambridge, and has been a visiting student at Harvard University.

Zoe Thomson
Zoe Thomson
Chief Innovation Officer & Co-Founder
LUCID
Zoe Thomson
Chief Innovation Officer & Co-Founder
LUCID
Andrew Phelan
Andrew Phelan
Chief Operating Officer
Beats Medical
Andrew Phelan
Chief Operating Officer
Beats Medical
Ema Kufel
Ema Kufel
Co-Founder & CEO Prosoma UK
Prosoma
Ema Kufel
Co-Founder & CEO Prosoma UK
Prosoma
Ihsan Almarzooqi
Ihsan Almarzooqi
Co-Founder & Managing Director
GluCare.Health
Ihsan Almarzooqi
Co-Founder & Managing Director
GluCare.Health
Simon Nelsen
Simon Nelsen
Chief Science & Innovation Officer
Brain+
Simon Nelsen
Chief Science & Innovation Officer
Brain+
Kadri Haljas
Kadri Haljas
Chief Executive Officer
Triumf Health
Kadri Haljas
Chief Executive Officer
Triumf Health
Hakim Yadi
Hakim Yadi
Chief Executive Officer
Closed Loop Medicine
Hakim Yadi
Chief Executive Officer
Closed Loop Medicine
Sona Sikorova
Sona Sikorova
Chief Executive Officer
Mindpax.me
Sona Sikorova
Chief Executive Officer
Mindpax.me
Gabriele Tundo
Gabriele Tundo
Partner
Plexus Ventures LLC
Gabriele Tundo
Partner
Plexus Ventures LLC
Lana Ghanem
Lana Ghanem
Vice President, Digital Health Investments & Partnerships
Hikma Pharmaceuticals
Lana Ghanem
Vice President, Digital Health Investments & Partnerships
Hikma Pharmaceuticals
Yury Roxenman
Yury Roxenman
SVP of Pharmaceutical & Life Sciences
Propeller Health
Yury Roxenman
SVP of Pharmaceutical & Life Sciences
Propeller Health

Yury Rozenman is the SVP of Pharmaceutical and Life Sciences at Propeller. In this role, he leads the company’s strategy, vision and oversees execution of all global business development activities. Prior to joining Propeller, Yury was the head of healthcare and life sciences industry partnerships at AWS where he was responsible for the development of life sciences vertical solutions, marketing programs, joint GTM strategy and execution on the global basis. Yury has 30 years of experience within the industry in pharmaceutical research and development both as a team leader and group research manager. He has worked in diagnostics and medical devices, and has been involved in the development and launch of world-class drugs and diagnostic tests.

Rana Lonnen
Rana Lonnen
Managing Director, dRx Capital
Novartis
Rana Lonnen
Managing Director, dRx Capital
Novartis
Geoff Wylde
Geoff Wylde
Head of B2B Business Development
Oura
Geoff Wylde
Head of B2B Business Development
Oura
Anish Shindore
Anish Shindore
Founder & Managing Partner
GSD Health
Anish Shindore
Founder & Managing Partner
GSD Health
Smit Patel
Smit Patel
Program Lead, Director of Digital Medicine
Digital Medicine Society
Smit Patel
Program Lead, Director of Digital Medicine
Digital Medicine Society
Lucy Jones
Lucy Jones
Vice President Clinical
Oviva
Lucy Jones
Vice President Clinical
Oviva
Mark Wuttke
Mark Wuttke
Chief Executive Officer
Dopavision
Mark Wuttke
Chief Executive Officer
Dopavision
Dan Ma
Dan Ma
Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany
Sandoz
Dan Ma
Head of Innovation & New Commercial Partnerships | Head Sandoz Innovation Lab Germany
Sandoz
Simon Spahrkäs
Simon Spahrkäs
Head of Research
Tired of Cancer
Simon Spahrkäs
Head of Research
Tired of Cancer
Susa Monacelli
Susa Monacelli
General Manager
Propeller Health
Susa Monacelli
General Manager
Propeller Health
Susa Monacelli is the General Manager of Propeller Health. In this role, she leads the company’s strategy and vision and oversees its Marketing, Commercial and Business Development activities. Susa is passionate about helping companies evolve from a fee-for-service model to value-based care, with the goal of providing predictive and preventive healthcare to patients with chronic disease. She previously held roles at ResMed, Propeller’s parent company; Onduo, a digital health company specializing in diabetes; and the Blue Cross Blue Shield Association, a health insurer providing care to more than 100 million people.
Arvind Tewari
Arvind Tewari
Vice President, Digital Products & Data
atai Life Sciences
Arvind Tewari
Vice President, Digital Products & Data
atai Life Sciences

Arvind joined atai Life Sciences in 2021 as Vice President, Digital Strategy and Operations, and is responsible for establishing and implementing atai’s Digital Therapeutics and Precision Psychiatry strategy. Prior to joining atai, Arvind was the Chief Operating Officer of Oxford VR, where he was responsible for Operations, Strategy, and Business Development. Oxford VR received Breakthrough Device designation from the FDA for the treatment of serious mental illnesses and was acquired by US operator BehaVR in 2022.

 

Before joining Oxford VR, Arvind was an Investment Manager at Epiris Private Equity (“Epiris”), where he was responsible for the buy-out, management, and digital transformation of companies between £100m – £500m in valuation. At Epiris, Arvind deployed and exited over £400m and £200m of capital respectively and sat on 9 Executive Boards. Arvind started his professional career at NM Rothschild & Sons where he was Vice President, Healthcare Mergers & Acquisitions.

 

Arvind holds a Bachelor’s and Master’s degree in Molecular and Cellular Biochemistry from the University of Oxford with dissertations in Cell Cycle Replication (Professor Kearsey) and Vaccinology (Dame Professor Gilbert).

Dirk Sauer
Dirk Sauer
Chairman of the Board
Dopavision
Dirk Sauer
Chairman of the Board
Dopavision
Alex Despotovic
Alex Despotovic
Program Lead
Digital Medicine Society
Alex Despotovic
Program Lead
Digital Medicine Society

Partner With Us

PARTNERSHIPS
The DTx summits are the premier events for senior executives from DTx companies, Pharma, Investors, HCPs and Payers.

DTx Europe 2023 is the 17th summit in the DTx series.  We believe that getting the right mix of partners is critical for a successful summit for you and our attendees. The DTx summit provides a rare opportunity to showcase your business to a world-class audience.

You will be impressed with our service and truthfulness. We will be honest with you throughout the process from deciding which option is right for you to delivery on-site.

Spaces are limited this year, please contact our commercial manager, Sam (sam@greygreenmedia.com) to discuss opportunities for involvement.

Contact Us +
Partner With Us

Register for the Event

For pricing and booking options please click the button to go to the registration page.

Registration